EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

RETROSPECTIVE STUDY OF ROLE OF COMPREHENSIVE DIABETES CARE IN KNOWN DIABETIC PATIENTS FROM UTTAR PRADESH REGION.

Rahul Mandole*

ABSTRACT

Background: Global burden of diabetes mellitus has increased consistently since past few decades. India has emerged as a major contributor to this global burden of DM. Comprehensive Diabetes Care (CDC) utilizes combination therapy of Panchkarma, administration of herbal drugs and diet therapy. Aim and objectives: The present study was planned to study the effectiveness of CDC therapy along with diet therapy in patients with type 2 DM attending Madhavbaug clinics in Uttar Pradesh, India. Materials and methods: This was a retrospective study conducted between September 2018 and September 2019, wherein we identified the data of obese patients suffering from type 2 DM (HbA1c ≥ 6.5%) of either gender and any age, and who had attended the out-patient departments (OPDs) at multiple Madhavbaug clinics located in Uttar Pradesh, India. The data of patients who had been administered CDC with minimum 6 sittings over a span of 12 weeks were considered for the study. Results: On analysing the results of HbA1c level in 124 patients who had completed 12 weeks of CDC therapy, it was found that controlled diabetes (HbA1c<5.7) was seen in 58 patients (46%) as compared to baseline (zero patient). The mean HbA1c levels reduced significantly from 8.7 at baseline to 7.03 at 12 weeks of CDC therapy. Other parameters like body mass index, body weight, cardio-pulmonary parameters showed improvement at the end of 12 week CDC therapy. Dependency on conventional allopathic medications was also reduced. Conclusion: From the findings of present study, CDC has been found to exert significant euglycemic action, and can serve as potent alternate option for management of DM.

Keywords: Diabetes mellitus, Comprehensive Diabetes Care, CDC, panchkarma, HbA1C, BMI.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 October 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 issue has been successfully launched on OCTOBER 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along witcertificate to promote resear activity of scholar.

Best Article of current issue :

Dr. Kartik Neog
Download Article : Click here